# A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other

> **NCT03905096** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 425809
- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT03905096
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-08-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03905096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03905096, "A Study in Healthy Men and Women to Test Which Effects Donepezil and BI 425809 Have on Each Other". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT03905096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*